Teamwork Financial Advisors, LLC Crispr Therapeutics Ag Transaction History

Teamwork Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	SELL	$100.84 - $161.89 $292,839 - $470,128	-2,904 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$110.72 - $210.04 $1.17 Million - $2.23 Million	-10,596 Reduced 78.49%	2,904 $354,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $239,010 - $519,689	3,000 Added 28.57%	13,500 $2.07 Million
Q3 2020 Oct 15, 2020	BUY	$78.5 - $100.64 $824,250 - $1.06 Million	10,500 New	10,500 $878,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Teamwork Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Teamwork Financial Advisors, LLC with notifications on news.